Combined short-term hepatitis B immunoglobulin (HBIG) and long-term lamivudine (LAM) versus HBIG monotherapy as hepatitis B virus (HBV) prophylaxis in liver transplant recipients

被引：0
|
作者：
Terrault, NA
Wright, TL
Roberts, JP
Ascher, NL
机构：
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[3] VAMC, San Francisco, CA USA
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
905
引用
收藏
页码：389A / 389A
页数：1
相关论文
共 50 条
  • [1] A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation
    Buti, M
    Mas, A
    Prieto, M
    Casafont, F
    Gonzalez, A
    Miras, M
    Herrero, JI
    Jardí, R
    de Castro, EC
    García-Rey, C
    JOURNAL OF HEPATOLOGY, 2003, 38 (06) : 811 - 817
  • [2] Combination prophylaxis with lamivudine (LAM) and hepatitis B immunoglobulin (HBIG) prevents graft re-infection by hepatitis B (HBV)
    Lai, V
    Elias, E
    O'Donnell, K
    Mutimer, D
    GUT, 2002, 50 : A115 - A115
  • [3] Conversion of liver transplant recipients with hepatitis B virus from hepatitis B immune globulin (HBIG) and lamivudine (LAM) to adefovir dipivoxil (ADV) and LAM
    Neff, G. W.
    Zacharias, V. C.
    Alonzo, M.
    Kemmer, N.
    Weber, F.
    Kaiser, T. E.
    Safdar, K.
    Rideman, E.
    Thomas, M.
    Martin, J.
    Rudich, S.
    Tevar, A.
    Buell, J.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S188 - S188
  • [4] Benefit of anti-hepatitis B immunoglobulin( HBIG) monotherapy compared to HBIG combined with entecavir in long term renal function
    Choi, M.
    Lee, J. G.
    Jung, Y. B.
    Kim, S., I
    Ju, M. K.
    Lee, J.
    Kim, H.
    TRANSPLANTATION, 2018, 102 : 314 - 314
  • [5] Individualizing Hepatitis B Prophylaxis in Liver Transplant (LT) Recipients: Diminished Need for Hepatitis B Immunoglobulin (HBIG)
    Radhakrishnan, Kavita
    Chi, Aileen
    Quan, David J.
    Roberts, John P.
    Terrault, Norah
    HEPATOLOGY, 2015, 62 : 971A - 972A
  • [6] Efficacy of combination prophylaxis with short-term HBIG and long-term lamivudine in preventing de novo hepatitis B infection in orthotopic liver transplant recipients with HBCAB positive donor.
    Kim, KM
    Choi, BH
    Hwang, S
    Park, KM
    Lee, YJ
    Lee, SG
    HEPATOLOGY, 2000, 32 (04) : 292A - 292A
  • [7] Combined therapy with low dose hepatitis B immunoglobulin (HBIG) and lamivudine (LAM) in patients transplanted for HBV chronic liver disease: Long term efficacy and costs
    Giusto, M.
    Gentili, F.
    Loria, I.
    Grieco, S.
    Rossi, M.
    Novelli, G.
    Berloco, P.
    Ferretti, G.
    Corradini, S. Ginanni
    Attili, A. F.
    Merli, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S84 - S84
  • [8] Benefit of Anti-hepatitis B Immunoglobulin (HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function
    Lee, J. G.
    Kim, D. G.
    Lee, J. J.
    Kim, S. H.
    Song, S. H.
    Lee, J. Y.
    Kwon, S. -K.
    Kim, M. S.
    Ju, M. K.
    Choi, G. H.
    Choi, J. S.
    Kim, S. I.
    Joo, D. J.
    TRANSPLANTATION, 2017, 101 (05) : 46 - 46
  • [9] Benefit of Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function
    Lee, J.
    Lee, J.
    Lee, J.
    Song, S.
    Lee, J.
    Kwon, S. -K.
    Kim, M.
    Choi, G.
    Kim, S.
    Joo, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 774 - 774
  • [10] Benefit of Anti-hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function
    Lee, Jae Geun
    Kim, Deok Gie
    Lee, Jung Jun
    Kim, Sung Hoon
    Song, Seung Hwan
    Lee, Jee Youn
    Kim, Myoung Soo
    Ju, Man Ki
    Choi, Gi Hong
    Choi, Jin Sub
    Kim, Soon Il
    Joo, Dong Jin
    TRANSPLANTATION, 2018, 102 : S127 - S127
12345